Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin 50 mcg vs 100 mcg for prevention of uterine atony
NCT01630187Phase 4Completed
- Sponsor
- Université Laval
- Start
- Apr 2012
- Primary completion
- Jul 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of carbetocin in uterine atony, postpartum hemorrhage (PPH), sponsored by Université Laval. Started Apr 2012; status: completed.
02
Drugs
carbetocin
03
Conditions
uterine atonypostpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT01630187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01630187.